| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Dec 07, 2018 | Dec 11, 2018 | Sharp John P CFO Secretary | Buy | Phasebio Pharmaceuticals Inc | PHAS | $3.84 | $19,200 | +50.00% |
| Feb 12, 2014 | Feb 15, 2014 | Sharp John P VP Finance CFO | Sell | Ligand Pharmaceuticals Inc | LGND | $74.74 | $6M | -83.11% |
| Dec 12, 2013 | Dec 16, 2013 | Sharp John P VP Finance CFO | Sell | Ligand Pharmaceuticals Inc | LGND | $53.44 | $37,408 | -3.81% |
| Dec 06, 2013 | Dec 09, 2013 | Sharp John P VP Finance CFO | Sell | Ligand Pharmaceuticals Inc | LGND | $56.08 | $336,480 | -25.35% |
| Nov 18, 2013 | Nov 20, 2013 | Sharp John P VP Finance CFO | Sell | Ligand Pharmaceuticals Inc | LGND | $53 | $59,519 | -4.53% |
| Aug 16, 2013 | Aug 20, 2013 | Sharp John P VP Finance CFO | Sell | Ligand Pharmaceuticals Inc | LGND | $42.75 | $320,619 | -23.68% |